课题基金 / 基金详情

Development of Carbon Nanoencapsulates for Biomedicine

Development of Carbon Nanoencapsulates for Biomedicine
生物医学用碳纳米胶囊的开发
批准号:
6405504
负责人:
ROBERT D BOLSKAR
金额:
$18.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-16 至 2003-03-31

项目摘要

项目成果

ROBERT D BOLSKAR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A newly discovered class of nanoscale materials, the metal-carbon nanoencapsulates, has considerable potential to improve on current molecular-based MRI contrast enhancing agents. Metal-carbon nanoencapsulates are 2 nm diameter and larger particles in which graphitic carbon layers encase single crystals of metals or metal carbides. Their continuous graphitic carbon shells are several layers thick and highly stable. This shell protects the metal nanocrystal from oxygen and water, prevents the metal from leaving the encapsulate, allows magnetic interactions between the metal and exterior molecules, and provides a scaffolding for chemical derivitization. These physical characteristics impart significant advantages to metal-carbon nanoencapsulates and will result in a safer, more effective class of novel MRI contrast enhancing agents based on metal-carbon nanoencapsulates. The nanoencapsulates will be aminated, allowing for solubilization and coupling reactions on the surface of the nanoencapsulate. The relaxivity characterisitics of gadolinium containing solubilized nanoencapsulates with be evaluated, and the covalent conjugation of proteins will be tested. Potential applications for these nanoencapsulate contrast agents include imaging of the blood pool, RES, cancerous lesions, and targeted imaging of receptors and gene expression. PROPOSED COMMERCIAL APPLICATION: The development of a new class of potent MRI contrast enhancing agents based on magnetic metal-carbon nanoencapsulates with higher stabilities, higher relaxivities, lower required in vivo concentrations and novel utility in target-specific imaging applications will have substantial commercial impact. Once fully developed, these safer and more powerful contrast enhancing agents will be in demand for clinical use in MRI laboratories and hospitals around the country in applications like MR angiography, imaging of reticuloendothelial system components, imaging of cancerous lesions with targeted agents, and for imaging gene expression and other receptors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Polymer Matrix for Dental Applications
  • 批准号:
    8646407
  • 项目类别:
  • 资助金额:
    $18.25万
  • 财政年份:
    2014
  • 负责人:
    ROBERT D BOLSKAR
  • 依托单位:
Perchlorate Sensing Platform for In-Field Groundwater Monitoring
  • 批准号:
    8781675
  • 项目类别:
  • 资助金额:
    $15.0万
  • 财政年份:
    2014
  • 负责人:
    ROBERT D BOLSKAR
  • 依托单位:
Quantum Dot Sensors for Superfund Priority Substances
  • 批准号:
    8455040
  • 项目类别:
  • 资助金额:
    $15.0万
  • 财政年份:
    2012
  • 负责人:
    ROBERT D BOLSKAR
  • 依托单位:
Fullerene Immunoconjugates for Cancer Imaging and Treatment
  • 批准号:
    7272908
  • 项目类别:
  • 资助金额:
    $20.09万
  • 财政年份:
    2007
  • 负责人:
    ROBERT D BOLSKAR
  • 依托单位:
国内基金
海外基金
一碳代谢(One carbon metabolism)介导上调的 PD1/PDL1 驱动 肿瘤免疫逃逸
  • 批准号:
    2024JJ9491
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    彭罗根
  • 依托单位:
三维碳纳米材料(nano-carbon@ZSM-5)的制备及应用
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    张兵
  • 依托单位:
理论预言的三维碳同素异构体T-carbon的制备及其物性的实验深入研究
  • 批准号:
    52072365
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    陈广超
  • 依托单位:
绿色热量运动驱动的G-Carbon系统碳生产力发展研究
  • 批准号:
    51976085
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2019
  • 负责人:
    傅敏
  • 依托单位: